Greatmark Investment Partners’s Gilead Sciences GILD Stock Holding History

Greatmark Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-500	Closed	-$39K	–	127
2018 Q3	$39K	Hold	500	–	–	0.01%	124
2018 Q2	$35K	Hold	500	–	–	0.01%	117
2018 Q1	$38K	Hold	500	–	–	0.01%	122
2017 Q4	$36K	Hold	500	–	–	0.01%	118
2017 Q3	$41K	Hold	500	–	–	0.02%	111
2017 Q2	$35K	Buy	+500	New	+$33.3K	0.01%	104

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Greatmark Investment Partners's GILD Position: Q2 2026 in Review

Greatmark Investment Partners reduced its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, selling an estimated $49.8K and leaving 28,312 shares worth $3.58M. The position accounts for 0.39% of the portfolio, ranked #49.

Greatmark Investment Partners first reported a position in GILD in Q2 2016 and has held it in 41 quarters since. The position peaked at $7.88M in Q2 2019. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Greatmark Investment Partners held 28,312 shares of Gilead Sciences worth $3.58M as of Q2 2026.
Greatmark Investment Partners sold 378 Gilead Sciences shares in Q2 2026, an estimated $49.8K.
Gilead Sciences made up 0.39% of Greatmark Investment Partners's portfolio in Q2 2026, its #49 holding.
Greatmark Investment Partners first reported a position in Gilead Sciences in Q2 2016 and has held it in 41 quarters since.
Greatmark Investment Partners's Gilead Sciences position peaked at $7.88M in Q2 2019.
1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Greatmark Investment Partners's 13F filing for Q2 2026, filed 24 Jul 2026.